171 related articles for article (PubMed ID: 18485214)
1. Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin.
Huang YJ; Lundy PM; Lazaris A; Huang Y; Baldassarre H; Wang B; Turcotte C; Côté M; Bellemare A; Bilodeau AS; Brouillard S; Touati M; Herskovits P; Bégin I; Neveu N; Brochu E; Pierson J; Hockley DK; Cerasoli DM; Lenz DE; Wilgus H; Karatzas CN; Langermann S
BMC Biotechnol; 2008 May; 8():50. PubMed ID: 18485214
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning.
Huang YJ; Huang Y; Baldassarre H; Wang B; Lazaris A; Leduc M; Bilodeau AS; Bellemare A; Côté M; Herskovits P; Touati M; Turcotte C; Valeanu L; Lemée N; Wilgus H; Bégin I; Bhatia B; Rao K; Neveu N; Brochu E; Pierson J; Hockley DK; Cerasoli DM; Lenz DE; Karatzas CN; Langermann S
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13603-8. PubMed ID: 17660298
[TBL] [Abstract][Full Text] [Related]
3. Characterization of butyrylcholinesterase from porcine milk.
Saxena A; Belinskaya T; Schopfer LM; Lockridge O
Arch Biochem Biophys; 2018 Aug; 652():38-49. PubMed ID: 29908755
[TBL] [Abstract][Full Text] [Related]
4. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization.
Raveh L; Grunwald J; Marcus D; Papier Y; Cohen E; Ashani Y
Biochem Pharmacol; 1993 Jun; 45(12):2465-74. PubMed ID: 8328984
[TBL] [Abstract][Full Text] [Related]
5. Reengineering of Albumin-Fused Cocaine Hydrolase CocH1 (TV-1380) to Prolong Its Biological Half-Life.
Cai Y; Zhou S; Jin Z; Wei H; Shang L; Deng J; Zhan CG; Zheng F
AAPS J; 2019 Nov; 22(1):5. PubMed ID: 31754920
[TBL] [Abstract][Full Text] [Related]
6. Low levels of endogenous cholinesterases support the choice of cows, sheep and goats for the transgenic expression of human butyrylcholinesterase in milk.
Belinskaya T; Saxena A
Chem Biol Interact; 2023 Sep; 383():110691. PubMed ID: 37659623
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris.
Huang YS; Chen Z; Chen YQ; Ma GC; Shan JF; Liu W; Zhou LF
J Pept Sci; 2008 May; 14(5):588-95. PubMed ID: 17994612
[TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase.
Chilukuri N; Parikh K; Sun W; Naik R; Tipparaju P; Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():115-21. PubMed ID: 16253215
[TBL] [Abstract][Full Text] [Related]
9. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity.
Duysen EG; Bartels CF; Lockridge O
J Pharmacol Exp Ther; 2002 Aug; 302(2):751-8. PubMed ID: 12130740
[TBL] [Abstract][Full Text] [Related]
10. Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion to human serum albumin.
Müller D; Karle A; Meissburger B; Höfig I; Stork R; Kontermann RE
J Biol Chem; 2007 Apr; 282(17):12650-60. PubMed ID: 17347147
[TBL] [Abstract][Full Text] [Related]
11. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.
Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y
Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953
[TBL] [Abstract][Full Text] [Related]
13. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.
Saxena A; Sun W; Luo C; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():199-203. PubMed ID: 16263104
[TBL] [Abstract][Full Text] [Related]
14. Tetramer-organizing polyproline-rich peptides differ in CHO cell-expressed and plasma-derived human butyrylcholinesterase tetramers.
Schopfer LM; Lockridge O
Biochim Biophys Acta; 2016 Jun; 1864(6):706-714. PubMed ID: 26947244
[TBL] [Abstract][Full Text] [Related]
15. Human plasma-derived butyrylcholinesterase is behaviorally safe and effective in cynomolgus macaques (Macaca fascicularis) challenged with soman.
Myers TM
Chem Biol Interact; 2019 Aug; 308():170-178. PubMed ID: 31129133
[TBL] [Abstract][Full Text] [Related]
16. Characterization of butyrylcholinesterase in bovine serum.
Dafferner AJ; Lushchekina S; Masson P; Xiao G; Schopfer LM; Lockridge O
Chem Biol Interact; 2017 Mar; 266():17-27. PubMed ID: 28189703
[TBL] [Abstract][Full Text] [Related]
17. Binding and biologic characterization of recombinant human serum albumin-eTGFBR2 fusion protein expressed in CHO cells.
Wan A; Miao Y; Peng L; Cai Y; Chen Y; He Y; Yang J; Jin J; Li H
Bioengineered; 2017 Sep; 8(5):600-612. PubMed ID: 28281868
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification and characterization of recombinant human interleukin-2-serum albumin (rhIL-2-HSA) fusion protein in Pichia pastoris.
Lei J; Guan B; Li B; Duan Z; Chen Y; Li H; Jin J
Protein Expr Purif; 2012 Jul; 84(1):154-60. PubMed ID: 22609631
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 5 monoclonal antibodies for immunopurification of human butyrylcholinesterase on Dynabeads: KD values, binding pairs, and amino acid sequences.
Peng H; Brimijoin S; Hrabovska A; Targosova K; Krejci E; Blake TA; Johnson RC; Masson P; Lockridge O
Chem Biol Interact; 2015 Oct; 240():336-45. PubMed ID: 26343001
[TBL] [Abstract][Full Text] [Related]
20. An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action.
Berger V; Richter F; Zettlitz K; Unverdorben F; Scheurich P; Herrmann A; Pfizenmaier K; Kontermann RE
Protein Eng Des Sel; 2013 Oct; 26(10):581-7. PubMed ID: 24006371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
